Maybe previously discussed, but where is everyone buying their GLP-1s? Looking for safe online source.

2 Likes

I’ve been looking into this today. Many forum discussions suggest that you can get Semaglutide (Rybelsus) pills for a lower price from vendors in India, like Jagdish and Maulik. Since I’m in the UK, getting a prescription seems unlikely, making this my only viable option. From what I understand, other forms of GLP1s require refrigeration, which complicates sourcing them internationally. If anyone has more accurate info or corrections, I’d appreciate the input as I’m still exploring this myself

3 Likes

new LLM:

Based on the search results, the safest sources for obtaining retatrutide online, with testing showing it contains the right product, are:

  1. Limitless Life: This vendor is highly recommended for sourcing retatrutide. They are known for their reputable research peptides and ensure the authenticity and quality of their supplements. Limitless Life tests each peptide batch through independent laboratories to guarantee its 99% purity and reliability.

  2. TruPeptides: This vendor offers retatrutide with a guarantee of over 99% purity and third-party testing. Every batch is tested by two laboratories, and these Certificates of Analysis (COAs) are available through the vial’s QR code.

  3. Select Peptides: This vendor provides retatrutide that is 100% lab tested. They offer fast and free shipping on orders over $150 within the USA.

It is important to note that retatrutide is not currently approved as a prescription medication and is not available for general use in the U.S. or other countries. The peptide remains under clinical investigation for its potential applications in managing weight and type 2 diabetes, but it is not available for consumer purchase. At present, retatrutide can only be legally obtained by qualified researchers who are conducting authorized studies.

Is this LLM output? If so, please mark it as such. If I’m looking for recommendations from the community, the last thing I want is random, potentially inaccurate output from an LLM.

6 Likes

Because of legal reasons, Tirzepatide will soon be very hard to obtain other than brand name.

For help in sourcing GLP-1s, one of the best sources is StairwaytoGray telegram server: over 5000 people so a lot of chatter, but they keep a good vendor and testing list in the group.

Peppys is good as well but you need an invite. Talk with GoodKitty here for more info.

3 Likes

Interested to see if you found a source for GLP1s. Also in the UK and just started looking into this myself and would be far from being able to qualify for a prescription on the NHS. Thanks C

I have not found a source for injectables in the UK, but I haven’t done much research. There are dedicated GLP-1 forums and groups I’ve seen mentioned that would offer some good information. Oral semaglutide can be bought from India, but it’s expensive. Let me know if you find a source that looks trustworthy.

https://x.com/_TomHoward/status/1928261690879266932

Related Links:

3 Likes

This is a very impressive project, thanks!

One of the many risks one runs when buying from single vial resellers. And they’re not the only ones. Avoid at all costs.

2 Likes

Short answer: no, Oasis doesn’t look ā€œoff the stated amountā€ more often than the retatrutide circus at large. The whole market’s a carnival of overfills and underfills, with Oasis sitting in the middle row eating popcorn.

Here’s the boring evidence you actually wanted:

  • Independent test hub Finnrick shows 7 Oasis retatrutide samples this year with quantity deltas from āˆ’1.6% to +14.5% vs label; average score ā€œB (Good).ā€ Examples: a 10 mg vial tested 9.98 mg (āˆ’0.2%), and a 5 mg vial tested 5.72 mg (+14.5%). (Finnrick)
  • Contrast: top-rated vendors also swing. Paradigm has mostly tight fills, but one 10 mg sample landed +15.2%; NextechLabs shows several double-digit overfills up to +26.3%. In other words, variance is not an Oasis-only hobby. (Finnrick)
  • Across the whole database (590 tests, 81 vendors), Finnrick reports purity from ~89.7% to 100% and quantity divergence up to ±109% vs advertised. It’s a jungle. (Finnrick)

Why does label vs actual swing this much? Because the supply chain’s held together with lab tape and vibes:

  1. Lyophilization and fill-weight error. Microgram-level weighing isn’t forgiving; moisture content, counter-ions, residual solvents and carrier excipients all nudge mass. Some vendors also deliberately overfill to hedge degradation and handling loss. (See vendor ā€œ99% purityā€ claims and COA language; they’re about purity, not accurate fill mass.) (myoasislabs.com)
  2. Batch heterogeneity and relabeling. Third-party resellers source from multiple manufacturers, then cap/label in-house; that’s how you get the same ā€œ10 mgā€ showing 9.98 mg one week and 11.1 mg the next. The test tables above literally show these swings by batch and cap color. (Finnrick)
  3. Testing methodology mismatch. HPLC area% purity isn’t potency; LC-MS confirms identity, not quantity; true quant requires validated reference standards or amino-acid analysis. Differences in labs and methods push numbers around. (Peptide Test)
  4. Regulatory grayness. FDA has been firing warning letters at compounders and GLP-1 adjacent sellers, including ones offering retatrutide. Gray markets correlate with sloppy QA. None of that proves a specific vendor is bad; it explains the chaos. (U.S. Food and Drug Administration)

Bottom line with the least amount of suffering:

  • Based on published third-party tests, Oasis is not an outlier for misfill on retatrutide; it’s average-to-decent in a messy ecosystem where even the ā€œAā€ vendors occasionally overshoot by double digits. (Finnrick)
  • If you insist on navigating this minefield, use independent COAs that include identity (LC-MS), purity (HPLC), and quantitative assays, or send a vial for testing before trusting the label. Finnrick publishes vendor comparisons and accepts mail-in samples; there are also standalone peptide testing services. Yes, it’s annoying. Yes, it’s necessary. (Finnrick)

And just so we’re clear: regulators consider retail retatrutide products unapproved and misbranded right now. If someone’s promising pristine pharma-grade accuracy in this channel, they’re selling dreams, not metrology. (U.S. Food and Drug Administration)

Here you go.

1 Like